impact factor, citescore
logo
In press
In Press
Recent issue
Recent issue
Recent Supplement
Recent supplement
archives
Archives
articles free
Free to view
Search
Search
 

One year in review

 

One year in review 2017: systemic vasculitis

1, 2, 3, 4, 5, 6, 7

 

  1. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  2. Department of Rheumatology, University of Pavia, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy.
  3. Clinic of Rheumatology, Department of Medical and Biological Sciences, University Hospital 'Santa Maria della Misericordia', Udine, Italy.
  4. Department of Clinical and Experimental Medicine, Division of Rheumatology, University of Florence, AOUC, Florence, Italy.
  5. Clinic of Rheumatology, Department of Medical and Biological Sciences, University Hospital 'Santa Maria della Misericordia', Udine, Italy.
  6. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  7. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy. chiara.baldini74@gmail.com

CER10374
2017 Vol.35, N°1 ,Suppl.103
PI 0005, PF 0026
One year in review

Free to view
(click on article PDF icon to read the article)

This article is also available as an online CME course. The course has been granted 5 (five) CME credits.

The registration and fruition of the online course is free of charge, the fee of EURO 25.00 (=20.49 + VAT) must be paid in order to obtain the credits.

This activity is valid for credit from June 24, 2017 through May 14, 2018.

Click here for more information on the CME activity.

PMID: 28375840 [PubMed]

Received: 28/02/2017
Accepted : 28/02/2017
In Press: 29/03/2017
Published: 19/04/2017

Abstract

Systemic vasculitis is a group of heterogeneous, disabling disorders. Great interest has recently arisen in pathophysiology, clinical phenotypes and therapy of large- and small-vessel vasculitis. The general work hypothesis has been to promote research focused on disease-related pathogenetic pathways, with the ultimate goal of identifying novel diagnostic and prognostic biomarkers, thus leading towards more effective targeted treatments. Following the previous annual reviews of this series, we will hereby provide a critical digest of the recent literature on small- and large-vessel systemic vasculitis, with a specific focus on novel possible disease-related biomarkers and their impact on current and future therapies.

Rheumatology Article